{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:35:41Z","timestamp":1776616541293,"version":"3.51.2"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Women with systemic lupus erythematosus exhibit a high prevalence of hypertension, endothelial dysfunction, and renal injury. We tested whether GW0742, a peroxisome proliferator activator receptor \u03b2\/\u03b4 (PPAR\u03b2\/\u03b4) agonist, ameliorates disease activity and cardiovascular complications in a female mouse model of lupus. Thirty-week-old NZBWF1 (lupus) and NZW\/LacJ (control) mice were treated with GW0742 or with the PPAR\u03b2\/\u03b4 antagonist GSK0660 plus GW0742 for 5 weeks. Blood pressure, plasma double-stranded DNA autoantibodies and cytokines, nephritis, hepatic opsonins, spleen lymphocyte populations, endothelial function, and vascular oxidative stress were compared in treated and untreated mice. GW0742 treatment reduced lupus disease activity, blood pressure, cardiac and renal hypertrophy, splenomegaly, albuminuria, and renal injury in lupus mice, but not in control. GW0742 increased hepatic opsonins mRNA levels in lupus mice and reduced the elevated T, B, Treg, and Th1 cells in spleens from lupus mice. GW0742 lowered the higher plasma concentration of proinflammatory cytokines observed in lupus mice. Aortae from lupus mice showed reduced endothelium-dependent vasodilator responses to acetylcholine and increased nicotinamide adenine dinucleotide phosphate oxidase\u2013driven vascular reactive oxygen species production, which were normalized by GW0742 treatment. All these effects of GW0742 were inhibited by PPAR\u03b2\/\u03b4 blockade with GSK0660. Pharmacological activation of PPAR\u03b2\/\u03b4 reduced hypertension, endothelial dysfunction, and organ damage in severe lupus mice, which was associated with reduced plasma antidouble-stranded DNA autoantibodies and anti-inflammatory and antioxidant effects in target tissues. Our findings identify PPAR\u03b2\/\u03b4 as a promising target for an alternative approach in the treatment of systemic lupus erythematosus and its associated vascular damage.<\/jats:p>","DOI":"10.1161\/hypertensionaha.116.08655","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T01:55:31Z","timestamp":1488246931000},"page":"641-650","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":35,"title":["Activation of Peroxisome Proliferator Activator Receptor \u03b2\/\u03b4 Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus"],"prefix":"10.1161","volume":"69","author":[{"given":"Miguel","family":"Romero","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Toral","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1aki","family":"Robles-Vera","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"O\u2019Valle","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Rodriguez-Nogales","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"P\u00e9rez-Vizcaino","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"G\u00e1lvez","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Duarte","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, School of Pharmacy (M.R., M.T., I.R.-V., M.S., R.J., A.R.-N., F.P.-V., J.G., J.D.), Department of Pathology, School of Medicine (F.O.), and CIBER-EHD, Center for Biomedical Research (CIBM) (J.G.), University of Granada, Spain; Instituto de Investigaci\u00f3n Biosanitaria de Granada, ibs.GRANADA, Spain (M.R., R.J., F.O., J.G., J.D.); CIBER Enfermedades Cardiovasculares, Granada, Spain (R.J., J.D.); Department of Pharmacology, School of Medicine, University Complutense..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308089988"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308089989"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.09.73"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009122"},{"key":"e_1_3_3_6_2","first-page":"493","article-title":"Cardiovascular risk factor screening in systemic lupus erythematosus.","volume":"30","author":"Al-Herz A","year":"2003","unstructured":"Al-Herz A, Ensworth S, Shojania K, Esdaile JM. Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol. 2003;30:493\u2013496.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307081113"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013010026"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04006"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri957"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2048"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01153.x"},{"key":"e_1_3_3_13_2","first-page":"32","article-title":"Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus.","volume":"26","author":"Bultink IE","year":"2008","unstructured":"Bultink IE, Turkstra F, Diamant M, Dijkmans BA, Voskuyl AE. Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26:32\u201338.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.174490"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvt152"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000634"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150111"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.05.004"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.233106"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025271"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.02.008"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(03)00207-5"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.90992.2008"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.157685"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03587"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040402"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.190009"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(88)90065-0"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402184"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.1997.v26.pm0009214457"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/849684"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.07.007"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.10934"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.10.710"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1976.03630090033009"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.4.1075"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.10.953"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.6.3223"},{"key":"e_1_3_3_39_2","first-page":"430","article-title":"B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells.","volume":"73","author":"Dar O","year":"1988","unstructured":"Dar O, Salaman MR, Seifert MH, Isenberg DA. B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells. Clin Exp Immunol. 1988;73:430\u2013435.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4296"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.39233"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00215"},{"key":"e_1_3_3_43_2","first-page":"273","article-title":"Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.","volume":"61","author":"Bijl M","year":"2003","unstructured":"Bijl M. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases. Neth J Med. 2003;61:273\u2013277.","journal-title":"Neth J Med"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.078212"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00168.2006"},{"key":"e_1_3_3_46_2","first-page":"57","article-title":"Cytokines in the pathogenesis of systemic lupus erythematosus.","volume":"19","author":"Kelley VR","year":"1999","unstructured":"Kelley VR, W\u00fcthrich RP. Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol. 1999;19:57\u201366.","journal-title":"Semin Nephrol"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091663"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000136807.78534.50"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.10.840"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.159806"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000243612.02929.df"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308093554"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603138"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-005-0018-z"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.340"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.34504"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu431"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.116.08655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:21:24Z","timestamp":1715592084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.116.08655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.116.08655"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.116.08655","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"2016-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}